Pharmacogenomics in the UK National Health Service: opportunities and challenges

Turner, Richard M ORCID: 0000-0002-7315-679X, Newman, William G, Bramon, Elvira, McNamee, Christine J, Wong, Wai Lup, Misbah, Siraj, Hill, Sue, Caulfield, Mark and Pirmohamed, Munir ORCID: 0000-0002-7534-7266
(2020) Pharmacogenomics in the UK National Health Service: opportunities and challenges. Pharmacogenomics, 21 (17). pp. 1237-1246.

[img] Text
Pharmacogenomics in the UK National Health Service 2020.docx - Author Accepted Manuscript

Download (46kB)


Despite increasing interest in pharmacogenomics, and the potential benefits to improve patient care, implementation into clinical practice has not been widespread. Recently, there has been a drive to implement genomic medicine into the UK National Health Service (NHS), largely spurred on by the success of the 100,000 Genomes Project. The UK Pharmacogenetics and Stratified Medicine Network, NHS England and Genomics England invited experts from academia, the healthcare sector, industry and patient representatives to come together to discuss the opportunities and challenges of implementing pharmacogenomics into the NHS. This report highlights the discussions of the workshop to provide an overview of the issues that need to be considered to enable pharmacogenomic medicine to become mainstream within the NHS.

Item Type: Article
Uncontrolled Keywords: Humans, Drug Therapy, Computational Biology, Pharmacogenetics, Education, Medical, State Medicine, Patient Education as Topic, Genetic Testing, Electronic Health Records, Precision Medicine, United Kingdom
Depositing User: Symplectic Admin
Date Deposited: 03 Feb 2021 09:37
Last Modified: 18 Jan 2023 23:01
DOI: 10.2217/pgs-2020-0091
Related URLs: